Bookedited by Arrigo F.G. Cicero, Manfredi Rizzo.
Summary: This book provides an evidence-based approach for the clinical use of nutraceuticals in the prevention and management of cardiovascular disease. It examines cardiovascular disease epidemiology, risk factors, and the role of dietary patterns. Clinical chapters discuss the use of nutraceuticals in the management of medical conditions such as dyslipidemia, hypertension, insulin resistance, and heart failure. Each chapter contains a short epidemiological background; a list of relevant active compounds and their efficacy, tolerability, and safety; and suggestions for prescribers. This book is a practical guide with the best clinical evidence supporting the use of nutraceuticals in cardiology. Nutraceuticals and Cardiovascular Disease: An Evidence-based Approach for Clinical Practice is an essential resource for physicians, residents, fellows, and medical students in cardiology, clinical nutrition, dietetics, and internal medicine.
Contents:
Chapter 1. Introduction to Cardiovascular Disease Epidemiology and Risk Factors
Chapter 2. Definition of Nutraceuticals (Both Scientific and Legal)
Chapter 3. Evidence-based Approach to Nutraceuticals in Cardiovascular Medicine
Chapter 4. Dietary Patterns and Cardiovascular Disease Risk: From Epidemiology to Intervention
Chapter 5. Single Dietary Components and Cardiovascular Disease Risk: From Epidemiology to Intervention
Chapter 6. Nutraceuticals for Dyslipidemia Management
Chapter 7. Nutraceuticals for Hypertension Management
Chapter 8. Nutraceuticals for Management of Insulin Resistance
Chapter 9. Nutraceuticals Supporting Body Weight Loss
Chapter 10. Nutraceuticals for Non-alcoholic Fatty Liver Disease Management
Chapter 11. Nutraceuticals for Homocysteine Reduction
Chapter 12. Nutraceuticals Supporting Cognitive Function in Mild Cognitive Impairment
Chapter 13. Nutraceuticals Supporting Heart Function in Heart Failure
Chapter 14. Nutraceuticals with Potential Adverse Cardiovascular Events or Pharmacological Interaction with Cardiometabolic Drugs.